Roshawn Blunt

Roshawn Blunt

Ms. Blunt has more than 25 years of experience in the biopharmaceutical and medical device industries. She is the president of Corsaire Corporation, a pharmaceutical commercialization organization.  Prior to that, Ms. Blunt founded and was the managing director of 1798, LLC, a national health care consulting firm. She began her pharmaceutical career at The Boston Consulting Group, working primarily in the health care industry. Prior to that, Ms. Blunt held a variety of strategic reimbursement and commercialization positions at Amgen, Inc. She was also the first global director of health economics and reimbursement for Biosense Webster, Inc., a Johnson & Johnson company. Prior to starting 1798 Consultants, Ms. Blunt was vice president of strategy, planning, and communication at Long Beach Memorial Center and Miller Children’s Hospital.

Ms. Blunt graduated from Princeton University, where she earned her A.B. from the Princeton School of Public and International Affairs, and she holds an MBA from Kellogg School of Management at Northwestern University.